Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for WORX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -0.0783M
March 31, 2026 -0.3181M
December 31, 2025 -0.1597M
September 30, 2025 -0.3581M
June 30, 2025 -0.6518M
March 31, 2025 -0.4046M
December 31, 2024 -0.1344M
September 30, 2024 -0.3626M
June 30, 2024 -0.5278M
March 31, 2024 -0.0595M
December 31, 2023 -0.1049M
September 30, 2023 -0.3728M
June 30, 2023 -0.3478M
March 31, 2023 0.0193M
December 31, 2022 -0.1123M
September 30, 2022 -0.3868M
June 30, 2022 0.0152M
March 31, 2022 -0.0628M
December 31, 2021 -0.3305M
September 30, 2021 -0.2555M
June 30, 2021 -0.057M
March 31, 2021 -0.4269M
Date Value
December 31, 2020 0.1865M
September 30, 2020 -0.1446M
June 30, 2020 -0.7141M
March 31, 2020 -0.2869M
December 31, 2019 -0.4406M
September 30, 2019 -0.3057M
June 30, 2019 -1.462M
March 31, 2019 -2.594M
December 31, 2018 -0.6477M
September 30, 2018 -0.2286M
June 30, 2018 0.6296M
March 31, 2018 0.0056M
December 31, 2017 -1.248M
September 30, 2017 -1.512M
June 30, 2017 -1.927M
March 31, 2017 -1.315M
December 31, 2016 -1.266M
September 30, 2016 -0.6188M
June 30, 2016 -0.1232M
March 31, 2016 -0.1222M
December 31, 2015 -0.1575M
September 30, 2015 -0.0747M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.055M
Health Catalyst, Inc. -5.182M
GoodRx Holdings, Inc. 66.42M
Claritev Corp. 54.59M
iSpecimen, Inc. -0.6896M